Navigation Links
NYU Steinhardt researchers to study why male millennials risk HIV transmission
Date:4/28/2014

The number of new HIV infections in the United States had remained steady in recent years, but rates among urban millennial gay, bisexual, and other young men who have sex with men (YMSM) have steadily increased in the past decade.

New York University researchers, led by Perry Halkitis, a professor at the Steinhardt School of Culture, Education, and Human Development, the Global Institute of Public Health, and NYU Langone Medical Center, will study this population in order to better understand the reasons for this increase under a five-year, $3.1 million grant from the National Institute on Drug Abuse, part of the National Institutes of Health.

The research is a continuation of a study of young men that began in 2009 under the name Project 18 (P18).

"The goal of this project is to understand why a new generation of YMSM place themselves at risk for HIV transmission," explains Halkitis, who is also associate dean for academic affairs at NYU's Global Institute of Public Health. "We aim to understand why some men exhibit risky behaviors as they emerge into adulthood while others do not."

The project's other researchers include three faculty in NYU Steinhardt's Public Health programFarzana Kapadia, the primary co-investigator, Danielle Ompad, and Rafael Perez Figueroaas well as Richard Greene, an assistant professor at NYU Langone Medical Center.

YMSM include not only gay men, but also those who are bisexual and heterosexual men but who have had sex with other men but do not identify as gay or bisexual.

Under the grant, the research team will continue its cohort study of nearly 600 racially, ethnically, and socioeconomically diverse YMSM that began when the subjects were in their late teens and who are now in their early 20s. The study will also expand this cohort and recruit some 300 additional men who are also now in their early 20s.

The study will consider several factors that may explain the rise in incidence rates, ranging from the behavioral to the structural, including the social and sexual networks of YMSM, the role of homophobia and discrimination in society, and the presence of other sexually transmitted infectionsas well as substance use and mental health burdens.

In addition, the researchers will consider the factors that explain both resilience and riskwhy some acquire HIV while others do not and how does the development of sexual risk coincide with other health conditions. The goal, they explain, is to move away from a program of research focused solely on deficit models and to also consider how new biomedical technologies such as PrEP (pre exposure prophylaxis) affect HIV health in a new generation of men.

Armed with greater insights into the factors that lead to growing rates of HIV among this population, the researchers will seek to create ways to address it, in part, as informed by the effective strategies some young men are utilizing.

"Working with community and municipal partners, we will draw from what we have learned to develop strategies for HIV prevention and intervention that are relevant to this current and developing generation who did not live through the devastation of the AIDS epidemic in the 1980s," says Halkitis.


'/>"/>

Contact: James Devitt
james.devitt@nyu.edu
212-998-6808
New York University
Source:Eurekalert

Related medicine news :

1. More alcohol and traffic laws mean fewer traffic deaths, NYU Steinhardt study concludes
2. Researchers generate immunity against tumor vessel protein
3. Researchers at LSTM part of the international team to sequence the tsetse genome
4. Oxygen diminishes the hearts ability to regenerate, researchers discover
5. Finnish team of researchers finds a mutation in a tumor of the jaw
6. Depressed? Researchers identify new anti-depressant mechanisms, therapeutic approaches
7. Life stressors trigger neurological disorders, researchers find
8. Penn researchers find link between sleep and immune function in fruit flies
9. Penn Medicine researchers uncover hints of a novel mechanism behind general anesthetic action
10. CU researchers discover target for treating dengue fever
11. BUSM researchers find anti-seizure drug may reduce alcohol consumption
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2017)... ... ... Hammer Strength, the world’s leading performance strength training brand, and the National Basketball ... NBSCA Strength & Conditioning Coach of the Year. , In its 11th year, ... the coach who embodies the highest level of excellence and outstanding service to their ...
(Date:6/27/2017)... North Hollywood, CA (PRWEB) , ... June 27, ... ... on orthodontic treatments . Orthodontics is a dental specialty that focuses on ... other appliances. Benefits include improved aesthetics and function. , North Hollywood ...
(Date:6/27/2017)... Washington DC (PRWEB) , ... June 27, 2017 , ... ... Report Best Children’s Hospitals rankings, with its Neonatology program ranking #1 out of ... was also named to the coveted Honor Roll, a distinction given to the ...
(Date:6/26/2017)... ... ... Dental Center is now offering various types of dental implants to restore lost teeth. ... prosthetic teeth, such as crowns, bridges, or dentures. An implant is placed directly into the ... for the tooth. , Several types of dental implants are available, including: , ...
(Date:6/26/2017)... (PRWEB) , ... June 26, 2017 , ... ... group in the country, today announced the hiring of Richard Robinson as chief ... diverse leadership and operations experience, with a proven track record of simplifying business ...
Breaking Medicine News(10 mins):
(Date:6/8/2017)... -- Less than a month ago, amateur hackers executed an ... hospital networks, in over 150 countries. The ... online extortion attempts ever recorded. With the increasing complexity ... that providers understand where the risks lie, and how ... many other very real cyber threats.  ...
(Date:6/7/2017)...  Novavax, Inc., (Nasdaq: NVAX ) today announced ... of its RSV F protein recombinant nanoparticle vaccine candidate (RSV ... published in the journal Vaccine (the ... scientific conferences). The Company previously announced top line results ... the RSV F Vaccine with the goal of protecting infants ...
(Date:6/3/2017)... June 3, 2017  Eli Lilly and Company ... results from the Phase 3 MONARCH 2 study ... 6 inhibitor, in combination with fulvestrant, significantly improved ... alone in women with hormone-receptor-positive (HR+), human epidermal ... who have relapsed or progressed after endocrine therapy ...
Breaking Medicine Technology: